United States · FDA National Drug Code directory
Eprontia
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 52652-9001_3feb6452-372c-4c60-8e91-220be75f90b1
- Product NDC
- 52652-9001
- Form
- SOLUTION
- Composition / generic term
- Topiramate
- Labeler
- Azurity Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20211206
- Source listing expiry
- 20271231
Source-listed ingredients
- TOPIRAMATE — 25 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 473 mL in 1 BOTTLE (52652-9001-1) · 52652-9001-1
- 1 BOTTLE in 1 CARTON (52652-9001-2) / 240 mL in 1 BOTTLE · 52652-9001-2
- 1 BOTTLE in 1 CARTON (52652-9001-3) / 120 mL in 1 BOTTLE · 52652-9001-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →